First Time Loading...

Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 128.26 USD -0.42% Market Closed
Updated: May 3, 2024

Merck & Co Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merck & Co Inc
Operating Income Peer Comparison

Comparables:
JNJ
BMY
PFE
ZTS
LLY

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Merck & Co Inc
NYSE:MRK
Operating Income
$6.6B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
-2%
Johnson & Johnson
NYSE:JNJ
Operating Income
$23.4B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$10.5B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Operating Income
$13.1B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
-3%
Zoetis Inc
NYSE:ZTS
Operating Income
$3.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
14%
Eli Lilly and Co
NYSE:LLY
Operating Income
$10.3B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
6%

See Also

What is Merck & Co Inc's Operating Income?
Operating Income
6.6B USD

Based on the financial report for Mar 31, 2024, Merck & Co Inc's Operating Income amounts to 6.6B USD.

What is Merck & Co Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-2%

Over the last year, the Operating Income growth was -64%. The average annual Operating Income growth rates for Merck & Co Inc have been -10% over the past three years , -11% over the past five years , and -2% over the past ten years .